Advertisement
Advertisement

BIO

BIO logo

Bio-Rad Laboratories, Inc.Class A

289.28
USD
Sponsored
+3.34
+1.17%
Jun 15, 16:00 UTC -4
Closed
exchange

After-Market

289.23

-0.05
-0.02%

BIO Earnings Reports

Positive Surprise Ratio

BIO beat 29 of 42 last estimates.

69%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$630.23M
/
$1.76
Implied change from Q1 26 (Revenue/ EPS)
+6.44%
/
-6.88%
Implied change from Q2 25 (Revenue/ EPS)
-3.28%
/
-32.57%

Bio-Rad Laboratories, Inc.Class A earnings per share and revenue

On Apr 30, 2026, BIO reported earnings of 1.89 USD per share (EPS) for Q1 26, missing the estimate of 2.00 USD, resulting in a -5.68% surprise. Revenue reached 592.10 million, compared to an expected 594.76 million, with a -0.45% difference. The market reacted with a -8.41% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 1.76 USD, with revenue projected to reach 630.23 million USD, implying an decrease of -6.88% EPS, and increase of 6.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Medtronic plc
Report Date
Jun 03, 2026 For Q4 26
Estimate
$1.55
Actual
$1.55
Surprise
-0.43%
logo
Aurora Cannabis Inc. Common Shares
Report Date
Jun 11, 2026 For Q4 26
Estimate
-$0.08
Actual
$0.09
Surprise
+213.92%
FAQ
For Q1 2026, Bio-Rad Laboratories, Inc.Class A reported EPS of $1.89, missing estimates by -5.68%, and revenue of $592.10M, -0.45% below expectations.
The stock price moved down -8.41%, changed from $280.12 before the earnings release to $256.55 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on 6 analysts, Bio-Rad Laboratories, Inc.Class A is expected to report EPS of $1.76 and revenue of $630.23M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement